Patents matching “BOARD OF REGENTS”

US 6423493

Combinatorial selection of oligonucleotide aptamers

The Board of Regents of the University of Texas System · Granted Jul 23, 2002 · Expires Jul 18, 2022

US 6419897

Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis

THE ARIZONA BOARD OF REGENTS · Granted Jul 16, 2002 · Expires Jul 11, 2022

US 6417244

Metal oxide compositions and methods

The Board of Regents of the University of Texas System · Granted Jul 9, 2002 · Expires Jul 4, 2022

US 6414115

Parasitic nematode transglutaminase proteins and uses thereof

The Board of Regents of the University of Texas System · Granted Jul 2, 2002 · Expires Jun 27, 2022

US 6410029

2-methoxyestradiol-induced apoptosis in cancer cells

The Board of Regents of the University of Texas System · Granted Jun 25, 2002 · Expires Jun 20, 2022

US 6410010

Recombinant P53 adenovirus compositions

The Board of Regents of the University of Texas System · Granted Jun 25, 2002 · Expires Jun 20, 2022

US 6406693

Cancer treatment methods using antibodies to aminophospholipids

The Board of Regents of the University of Texas System · Granted Jun 18, 2002 · Expires Jun 13, 2022

US 6405069

Time-resolved optoacoustic method and system for noninvasive monitoring of glucose

The Board of Regents of the University of Texas System · Granted Jun 11, 2002 · Expires Jun 6, 2022

US 6399368

Secretion of T cell receptor fragments from recombinant Escherichia coli cells

The Board of Regents of the University of Texas System · Granted Jun 4, 2002 · Expires May 30, 2022

US 6399633

Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation

The Board of Regents of the University of Texas System · Granted Jun 4, 2002 · Expires May 30, 2022

US 6395510

Vertebrate apoptosis gene: compositions and methods

The Board of Regents of the University of Michigan · Granted May 28, 2002 · Expires May 23, 2022

US 6395712

Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy

The Board of Regents of the University of Texas System · Granted May 28, 2002 · Expires May 23, 2022

US 6391049

Solid biodegradable device for use in tissue repair

The Board of Regents of the University of Texas System · Granted May 21, 2002 · Expires May 16, 2022

US 6391554

Detecting cancerous conditions by assaying for telomerase activity

Geron Corporation and Board of Regents · Granted May 21, 2002 · Expires May 16, 2022

US 6379664

Composition and method for the prevention and treatment of oxidative damage in ocular tissues

BOARD OF REGENTS UNIVERSITY OF NEBRASKA-LINCOLN · Granted Apr 30, 2002 · Expires Apr 25, 2022

US 6375930

Membrane incorporation of texaphyrins

The Board of Regents of the University of Texas System · Granted Apr 23, 2002 · Expires Apr 18, 2022

US 6372957

Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use

The Board of Regents of the University of Texas System · Granted Apr 16, 2002 · Expires Apr 11, 2022

US 6372455

Recombinant vaccinia viral vectors

THE ARIZONA BOARD OF REGENTS · Granted Apr 16, 2002 · Expires Apr 11, 2022

US 6368596

Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells

The Board of Regents of the University of Texas System · Granted Apr 9, 2002 · Expires Apr 4, 2022

US 6362322

Conversion of a watson-crick DNA to a hoogsteen-paired duplex

The Board of Regents of the University of Texas System · Granted Mar 26, 2002 · Expires Mar 21, 2022

US 6362200

Antitumor dibenzofluorene derivatives

The Board of Regents of the University of Texas System · Granted Mar 26, 2002 · Expires Mar 21, 2022

US 6359158

Methods and products related to 16-HETE analogs

THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Mar 19, 2002 · Expires Mar 14, 2022

US 6355619

Peptide tumor cell growth inhibitors

The Board of Regents of the University of Texas System · Granted Mar 12, 2002 · Expires Mar 7, 2022

US 6350729

Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein

The Board of Regents of the University of Texas System · Granted Feb 26, 2002 · Expires Feb 21, 2022